SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The total revenue stands at Rs. 1484.63 millions for the March 2025 quarter. The mentioned figure indicates an increase of about 102.64% as against Rs. 732.66 millions during  the year-ago period.The Total revenue for the quarter ended March 2025 of  Rs. 175.02  millions  grew by 159.40% from Rs. 67.47 millions.Operating Profit saw a handsome growth to 243.75 millions from 116.75 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1484.63 732.66 102.64 4628.49 2583.60 79.15 4628.49 2583.60 79.15
Other Income 69.03 28.71 140.44 171.91 131.01 31.22 171.91 131.01 31.22
PBIDT 243.75 116.75 108.78 706.97 409.55 72.62 706.97 409.55 72.62
Interest 0.89 11.70 -92.39 8.50 44.49 -80.89 8.50 44.49 -80.89
PBDT 242.94 105.05 131.26 698.53 364.82 91.47 698.53 364.82 91.47
Depreciation 12.86 12.98 -0.92 51.94 47.22 10.00 51.94 47.22 10.00
PBT 230.08 92.07 149.90 646.59 317.60 103.59 646.59 317.60 103.59
TAX 55.06 24.60 123.82 157.87 81.36 94.04 157.87 81.36 94.04
Deferred Tax 10.05 0.43 2237.21 13.34 5.54 140.79 13.34 5.54 140.79
PAT 175.02 67.47 159.40 488.72 236.24 106.87 488.72 236.24 106.87
Equity 940.00 940.00 0.00 940.00 940.00 0.00 940.00 940.00 0.00
PBIDTM(%) 16.42 15.94 3.03 15.27 15.85 -3.64 15.27 15.85 -3.64

Syncom Formulations Share Price

13.46 -0.43 (-3.10%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×